Study in BioRisk explores the use of Raman spectroscopy for rapid identification of Pseudomonas aeruginosa, a bacteria causing serious human diseases, demonstrating its potential as a quick and efficient diagnostic tool.
TARGET CORRIDOR FOR ADJUSTED EBIT MARGIN CONFIRMED WITH ADJUSTMENT TO 2024 SALES GUIDANCE – Biotech Investments
STRATEC SE / Key word(s): Preliminary Results/Change in Forecast STRATEC POSTS PRELIMINARY RESULTS FOR FIRST NINE MONTHS OF 2024: TARGET CORRIDOR FOR ADJUSTED EBIT MARGIN